Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 340, 577168
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD)Journal of the Neurological Sciences, 2020
- Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrenceNeurology Neuroimmunology & Neuroinflammation, 2020
- Area postrema syndromeNeurology, 2018
- International consensus diagnostic criteria for neuromyelitis optica spectrum disordersNeurology, 2015
- Neuromyelitis optica unique area postrema lesionsNeurology, 2011
- Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titreBrain, 2007
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006
- Establishment of a New Sensitive Assay for Anti-Human Aquaporin-4 Antibody in Neuromyelitis OpticaThe Tohoku Journal of Experimental Medicine, 2006
- IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channelJournal of Experimental Medicine, 2005
- Rating neurologic impairment in multiple sclerosisNeurology, 1983